- SEK965.73m
- SEK836.63m
- SEK441.90m
Brief: C-Rad To Repurchase Class B Shares
Brief: C Rad To Repurchase Up To 600,000 Class B Shares
Brief: C-Rad, Seetreat Partner On Personalised Radiotherapy
Brief: C Rad Q2 EBIT At SEK 38 Million
Sweden's C-Rad Q2 revenue rises as EMEA drives growth
Brief: C-Rad, SeeTreat Partner To Deliver Radiotherapy
Brief: C Rad Q1 Adjusted EBIT SEK 22 Mln
Brief: C Rad Q4 Order Intake Decreased 10% To SEK 151 Mln
Brief: C-RAD Appoints Tomas Blomquist As CEO
Brief: C-RAD Q3 EBIT Up At SEK 21.2 Mln
Brief: C-Rad CEO To Leave
Brief: C-Rad Wins Order From From Czech Hospital
Brief: C-Rad, IRT Systems Announce Partnership To Advance Safety In Radiotherapy
Brief: C Rad Order Intake Increased 6% To SEK 134.8 Mln
Brief: C-Rad Gets SEK 8 Mln Order With U.S. Healthcare Provider
Brief: C Rad Signs Contract Valued At SEK 9 Mln
Brief: C Rad Q1 Order Intake Up By 5% To SEK 96.5 Mln
Brief: C Rad Proposes No Dividend Is Paid For 2024 Financial Year
Brief: C Rad Q3 Order Intake Falls To SEK 99.6 Mln